Scientists at deCODE genetics and collaborators have published a study in the Journal of Allergy and Clinical Immunology ...

"Tivic hits enrolment target for vagus nerve stimulation trial" was originally created and published by Medical Device ...

Researchers at Ayass Bioscience have discovered and developed AYA22A aptamers, molecular compounds that target and bind to ...

Analyst Ami Fadia of Needham maintained a Buy rating on Blueprint Medicines (BPMC – Research Report), retaining the price target of ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

GOP Senator Rand Paul's report on wasteful spending prompted a repost from Musk, who is spinning up an anti-wase project for ...

His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.

Trends in child health are in fact worrisome, and scientists welcome a renewed focus on foods and environmental toxins. But ...

Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in Journal of Allergy and ...

French drug major Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the U.S. Food and Drug Administration ...

Brian Kemp Dolliver; Analyst; Brookline Capital Markets Douglas Tsao; Analyst; H.C. Wainwright & Co LLC ...

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...